Patients taking etizolam alone prior to development of blepharospasm
| Onset age (years) | Sex | Dose (mg/day) | Duration (years) | Drug use stopped | Outcome* |
|---|---|---|---|---|---|
| *Follow up period >6 months. Improved 1: patient reported improvement but still required botulinum toxin. Improved 2: patient became asymptomatic without any further treatment. | |||||
| 68 | F | 0.25/2 days | 9 | Yes | Improved 1 |
| 28 | F | 0.5/2 days | 1 month | Yes | Improved 2 |
| 58 | F | 0.5/2 days | 3 | Yes | Improved 1 |
| 51 | F | 0.5 | 2 months | Yes | Improved 2 |
| 57 | M | 0.5 | 10 months | Yes | Improved 1 |
| 63 | F | 0.5 | 1 | Changed drug | No change |
| 62 | F | 0.5 | 17 months | Yes | No change |
| 41 | F | 0.5 | 5 | Yes | Improved 1 |
| 28 | F | 0.5 | 6 | No | No change |
| 52 | F | 0.5 | 7 | Yes | No change |
| 67 | F | 1.0 | 6 | Reduced to 0.5 mg | No change |
| 57 | F | 1.0 | 12 | No | No change |
| 42 | F | 1.5 | 10 | Yes | Improved 1 |